STOCK TITAN
  1. Home
  2. Financials
  3. ONC
  4. EPS (Diluted)

BeOne Medicines Ltd. (ONC) EPS by Year

ONC

BeOne Medicines Ltd. earned $0.19 per diluted share in fiscal year 2025. This represents an increase of 140.4% from the prior fiscal year. Over the trailing 12 months, Q3 FY2025 through Q2 FY2026, the same line adds up to $0.43 per diluted share. The table below carries 12 fiscal years, from 2014 to 2025, and the quarters BeOne Medicines Ltd. has filed alongside them.

FY2025 annual
EPS (Diluted) $0.19
YoY +140.4%
Source SEC Filings (10-K/10-Q) Latest period Q2 FY2026, ended Jun 30, 2026 Reported Currency USD

Annual figures, oldest first. Point at a bar to read its period.

ONC EPS (Diluted) by Fiscal Year

Figures are as reported in USD. Each change compares the year with the year before it, and each column links to the filing it was taken from.

MetricTTMFY2510-KFY2410-KFY2310-KFY2210-KFY2110-KFY2010-KFY1910-KFY1810-KFY1710-KFY1610-KFY1510-KFY1410-K
EPS (Diluted)$0.43$0.19+140.4%-$0.47+27.7%-$0.65+56.4%-$1.49-23.1%-$1.21+19.3%-$1.50-23.0%-$1.22N/AN/AN/AN/AN/A

TTM is the trailing twelve months, Q3 FY2025 through Q2 FY2026, summed from the four most recent quarterly filings.

ONC EPS (Diluted) by Quarter

Figures are as reported in USD. Each change compares the quarter with the same quarter a year earlier.

MetricQ2'2610-QQ1'2610-QQ4'2510-QQ3'2510-QQ2'2510-QQ1'2510-QQ4'2410-KQ3'2410-QQ2'2410-QQ1'2410-QQ4'2310-KQ3'2310-Q
EPS (Diluted)$0.16+166.7%$0.15$0.04+136.4%$0.08+188.9%$0.06+166.7%$0.00+100.0%-$0.11+59.3%-$0.09-160.0%-$0.09+67.9%-$0.19+26.9%-$0.27+18.2%$0.15+136.6%

What diluted earnings per share means

Diluted earnings per share divides net income by the share count the company would have if every option and convertible security were exercised, which is the more conservative of the two per-share figures a filer reports.

More BeOne Medicines Ltd. financials

Frequently Asked Questions

What was BeOne Medicines Ltd.'s diluted earnings per share in fiscal year 2025?

BeOne Medicines Ltd. earned $0.19 per diluted share in fiscal year 2025.

How fast is BeOne Medicines Ltd.'s diluted earnings per share growing?

BeOne Medicines Ltd. (ONC) diluted earnings per share rose by 140.4% year over year, from -$0.47 to $0.19 in fiscal year 2025.

What is BeOne Medicines Ltd.'s diluted earnings per share over the last twelve months?

BeOne Medicines Ltd. (ONC) reported $0.43 per diluted share over the trailing 12 months, Q3 FY2025 through Q2 FY2026, summed from the four most recent quarterly filings.

BeOne Medicines Ltd. (ONC) reported $0.16 in diluted earnings per share in Q2 2026. This represents an increase of 166.7% from the same quarter a year earlier.

Diluted earnings per share divides net income by the share count the company would have if every option and convertible security were exercised, which is the more conservative of the two per-share figures a filer reports. This page lists what BeOne Medicines Ltd. (ONC) reported on that line in every period on record.